论著

舌鳞状细胞癌根治性切除术后患者预后预测列线图的构建与验证

  • 苏俊琪 ,
  • 王晓颖 ,
  • 孙志强
展开
  • 1. 北京大学口腔医学院·口腔医院检验科,国家口腔医学中心,国家口腔疾病临床医学研究中心,口腔生物材料和数字诊疗装备国家工程研究中心,北京 100081
    2. 北京大学口腔医学院·口腔医院病案管理科,国家口腔医学中心,国家口腔疾病临床医学研究中心,口腔生物材料和数字诊疗装备国家工程研究中心,北京 100081

收稿日期: 2023-08-30

  网络出版日期: 2024-02-06

Establishment and verification of a prognostic nomogram for survival of tongue squamous cell carcinoma patients who underwent cervical dissection

  • Junqi SU ,
  • Xiaoying WANG ,
  • Zhiqiang SUN
Expand
  • 1. Department of Clinical Laboratory, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing 100081, China
    2. Department of Medical Record, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing 100081, China

Received date: 2023-08-30

  Online published: 2024-02-06

摘要

目的: 评估术前炎症生物标志物、预后营养指数和临床病理特征对舌鳞状细胞癌(tongue squamous cell carcinoma, TSCC)患者行根治性切除术后生存结局的预后价值, 并以此构建患者预后预测列线图模型。方法: 回顾性收集2017年1月至2018年7月于北京大学口腔医院接受根治性肿瘤切除术的297例TSCC患者的病例资料, 随机按照7 :3比例分为训练集和验证集。分析患者术前全身炎症反应标志物中性粒细胞/淋巴细胞比率(neutrophil-to-lymphocyte ratio, NLR)、淋巴细胞/单核细胞比率(lymphocyte-to-monocyte ratio, LMR)、血小板/淋巴细胞比率(platelet-to-lymphocyte ratio, PLR)、系统免疫炎症指数(systemic immune-inflammation index, SII)、系统性炎症评分(systemic inflammation score, SIS)及预后营养指数(prognostic nutritional index, PNI)与TSCC患者术后总生存期(overall survival, OS)和疾病特异性生存期(disease-specific survival, DSS)的相关性。使用X-tile软件确定连续变量的最佳截断值作为分界点。采用Kaplan-Meier生存分析和多变量Cox回归模型分析影响TSCC患者的独立预后预测因素, 据此构建OS和DSS的生存相关列线图预测模型, 通过训练集和验证集进行模型内部交叉验证和外部验证, 具体通过一致性指数、时间依赖性受试者工作特征(receiver operating characteristic, ROC)曲线、曲线下面积(area under the curve, AUC)、校准曲线和决策曲线分析对列线图的准确性进行验证。结果: 单因素Cox回归分析显示, TNM分期、T分期、N分期、分化程度、侵袭深度(depth of invasion, DOI)、肿瘤直径和治疗前PNI水平为影响TSCC预后危险因素; 多因素Cox回归分析显示, 治疗前PNI水平、N分期、DOI和肿瘤直径为患者5年OS或DSS的独立预后因素(P<0.05)。治疗前N分期≥1、PNI≤50.65和DOI>2.4 cm与较差的5年OS显著相关, 而N分期≥1、PNI≤50.65、肿瘤直径>3.4 cm与较差的5年DSS显著相关。基于独立预后因素构建的TSCC术后患者OS和DSS的列线图预测模型的一致性指数分别为0.708 (95%CI, 0.625~0.791)和0.717 (95%CI, 0.600~0.834), 验证集验证结果显示, OS和DSS列线图预测模型的一致性指数为0.659 (95%CI, 0.550~0.767)和0.780 (95%CI, 0.669~0.890)。OS列线图模型和DSS列线图模型的1年、3年和5年的时间依赖性ROC分析(AUC分别为0.66、0.71、0.72和0.68、0.77、0.79)表明模型具有稳定的判别能力。校准曲线显示OS和DSS预测估值与实际观察值之间具有良好的一致性, 决策曲线分析反映模型具有较好的临床应用价值。结论: 治疗前PNI、N分期、DOI和肿瘤直径可能对TSCC患者的OS和DSS有可靠的预测价值, 基于这些参数构建的预后预测列线图在预测TSCC根治性切除术后患者的OS和DSS方面表现出良好的准确性和有效性, 是评估生存结局的有效工具, 有助于选择有针对性的联合治疗来改善患者预后。

本文引用格式

苏俊琪 , 王晓颖 , 孙志强 . 舌鳞状细胞癌根治性切除术后患者预后预测列线图的构建与验证[J]. 北京大学学报(医学版), 2024 , 56(1) : 120 -130 . DOI: 10.19723/j.issn.1671-167X.2024.01.019

Abstract

Objective: To evaluate the prognostic significance of inflammatory biomarkers, prognostic nutritional index and clinicopathological characteristics in tongue squamous cell carcinoma (TSCC) patients who underwent cervical dissection. Methods: The retrospective cohort study consisted of 297 patients undergoing tumor resection for TSCC between January 2017 and July 2018. The study population was divided into the training set and validation set by 7 :3 randomly. The peripheral blood indices of interest were preoperative neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation score (SIS) and prognostic nutritional index (PNI). Kaplan-Meier survival analysis and multivariable Cox regression analysis were used to evaluate independent prognostic factors for overall survival (OS) and disease-specific survival (DSS). The nomogram's accuracy was internally validated using concordance index, receiver operating characteristic (ROC) curve, area under the curve (AUC), calibration plot and decision curve analysis. Results: According to the univariate Cox regression analysis, clinical TNM stage, clinical T category, clinical N category, differentiation grade, depth of invasion (DOI), tumor size and pre-treatment PNI were the prognostic factors of TSCC. Multivariate Cox regression analysis revealed that pre-treatment PNI, clinical N category, DOI and tumor size were independent prognostic factors for OS or DSS (P < 0.05). Positive neck nodal status (N≥1), PNI≤50.65 and DOI > 2.4 cm were associated with the poorer 5-year OS, while a positive neck nodal status (N≥1), PNI≤50.65 and tumor size > 3.4 cm were associated with poorer 5-year DSS. The concordance index of the nomograms based on independent prognostic factors was 0.708 (95%CI, 0.625-0.791) for OS and 0.717 (95%CI, 0.600-0.834) for DSS. The C-indexes for external validation of OS and DSS were 0.659 (95%CI, 0.550-0.767) and 0.780 (95%CI, 0.669-0.890), respectively. The 1-, 3- and 5-year time-dependent ROC analyses (AUC = 0.66, 0.71 and 0.72, and AUC = 0.68, 0.77 and 0.79, respectively) of the nomogram for the OS and DSS pronounced robust discriminative ability of the model. The calibration curves showed good agreement between the predicted and actual observations of OS and DSS, while the decision curve confirmed its pronounced application value. Conclusion: Pre-treatment PNI, clinical N category, DOI and tumor size can potentially be used to predict OS and DSS of patients with TSCC. The prognostic nomogram based on these variables exhibited good accurary in predicting OS and DSS in patients with TSCC who underwent cervical dissection. They are effective tools for predicting survival and helps to choose appropriate treatment strategies to improve the prognosis.

参考文献

1 Panarese I , Aquino G , Ronchi A , et al. Oral and oropharyngeal squamous cell carcinoma: Prognostic and predictive parameters in the etiopathogenetic route[J]. Expert Rev Anticancer Ther, 2019, 19 (2): 105- 119.
2 Faisal M , Abu Bakar M , Sarwar A , et al. Depth of invasion (DOI) as a predictor of cervical nodal metastasis and local recurrence in early stage squamous cell carcinoma of oral tongue (ESSCOT)[J]. PLoS One, 2018, 13 (8): e0202632.
3 Ibrahim SA , Ahmed ANA , Elsersy HA , et al. Elective neck dissection in T1/T2 oral squamous cell carcinoma with N0 neck: Essential or not? A systematic review and meta-analysis[J]. Eur Arch Otorhinolaryngol, 2020, 277 (6): 1741- 1752.
4 Lu Z , Yan W , Liang J , et al. Nomogram based on systemic immune-inflammation index to predict survival of tongue cancer patients who underwent cervical dissection[J]. Front Oncol, 2020, 10, 341.
5 Jia B , Dao J , Han J , et al. LINC00958 promotes the proliferation of TSCC via miR-211-5p/CENPK axis and activating the JAK/STAT3 signaling pathway[J]. Cancer Cell Int, 2021, 21 (1): 147.
6 Almangush A , Pirinen M , Youssef O , et al. Risk stratification in oral squamous cell carcinoma using staging of the eighth American Joint Committee on Cancer: Systematic review and meta-analysis[J]. Head Neck, 2020, 42 (10): 3002- 3017.
7 Wei PY , Li WY , Tai SK . Discrete perineural invasion focus number in quantification for T1-T2 oral squamous cell carcinoma[J]. Otolaryngol Head Neck Surg, 2019, 160 (4): 635- 641.
8 Shi J , Bao X , Liu Z , et al. Serum miR-626 and miR-5100 are promising prognosis predictors for oral squamous cell carcinoma[J]. Theranostics, 2019, 9 (4): 920- 931.
9 Romani C , Salviato E , Paderno A , et al. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma[J]. Theranostics, 2021, 11 (6): 2987- 2999.
10 Zhang J , Hu Z , Horta CA , et al. Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics[J]. Semin Cancer Biol, 2023, 88, 46- 66.
11 Mariani P , Russo D , Maisto M , et al. Pre-treatment neutrophil-to-lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: Meta-analysis and trial sequential analysis[J]. J Oral Pathol Med, 2022, 51 (1): 39- 51.
12 Kumarasamy C , Tiwary V , Sunil K , et al. Prognostic utility of platelet-lymphocyte ratio, neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in head and neck cancers: A detailed PRISMA compliant systematic review and meta-analysis[J]. Cancers (Basel), 2021, 13 (16): 4166.
13 Xu X , Jing J . Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma[J]. Front Oncol, 2022, 12, 900305.
14 Wang Y , Lyu J , Jia H , et al. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy[J]. Future Oncol, 2021, 17 (20): 2647- 2657.
15 Wang D , Hu X , Xiao L , et al. Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC[J]. J Gastrointest Surg, 2021, 25 (2): 421- 427.
16 Murthy P , Zenati MS , Al Abbas AI , et al. Prognostic value of the systemic immune-inflammation index (SII) after neoadjuvant therapy for patients with resected pancreatic cancer[J]. Ann Surg Oncol, 2020, 27 (3): 898- 906.
17 Chang Y , An H , Xu L , et al. , Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma[J]. Br J Cancer, 2015, 113 (4): 626- 633.
18 Kim MG , Choi YS , Youn SM , et al. Treatment outcomes and prognostic factors in oral tongue cancer: A 20-year retrospective study at the National Cancer Center, South Korea[J]. J Korean Assoc Oral Maxillofac Surg, 2022, 48 (4): 192- 200.
19 Wolfer S , Elstner S , Schultze-Mosgau S . Degree of keratinization is an independent prognostic factor in oral squamous cell carcinoma[J]. J Oral Maxillofac Surg, 2018, 76 (2): 444- 454.
20 Ravasco P , Monteiro-Grillo I , Vidal PM , et al. Nutritional deterioration in cancer: The role of disease and diet[J]. Clin Oncol (R Coll Radiol), 2003, 15 (8): 443- 450.
21 Jiang Y , Xu D , Song H , et al. Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: A systematic review and meta-analysis[J]. BMJ Open, 2021, 11 (9): e048324.
22 Kono T , Sakamoto K , Shinden S , et al. Pre-therapeutic nutri-tional assessment for predicting severe adverse events in patients with head and neck cancer treated by radiotherapy[J]. Clin Nutr, 2017, 36 (6): 1681- 1685.
23 Yoshimura T , Suzuki H , Takayama H , et al. Prognostic value of inflammatory biomarkers in aged patients with oral squamous cell carcinoma[J]. Front Pharmacol, 2022, 13, 996757.
24 Kubota K , Ito R , Narita N , et al. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment[J]. BMC Cancer, 2022, 22 (1): 368.
文章导航

/